In the second half of 2020 medtech began a tentative – and possibly short-lived – recovery.
Welcome to the calm before the Covid-19 storm.
2019 was an average year for medtech M&A. 2020, not so much.
Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.
Two dental companies go public inside a week, with very different results.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Some medtech stocks did decline in 2018, but many more increased in value.
Big cap medtech is hiring, largely thanks to organic growth.